Canada· CA-DIN-02524031
PAXLOVID
A nirmatrelvir und ritonavir product containing nirmatrelvir + ritonavir, registered in Canada by PFIZER CANADA ULC. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Nirmatrelvir und ritonavir is registered in 11 of 19 countries.
Countries holding a registration under ATC J05AE30 (nirmatrelvir und ritonavir), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Nirmatrelvir und ritonavir · ATC J05AE30
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of nirmatrelvir und ritonavir costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nirmatrelvir und ritonavir · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$851.25
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- NIRMATRELVIR + RITONAVIR
- Manufacturer
- PFIZER CANADA ULC
- Country
- Canada (CA)
- ATC code
- J05AE30
- ATC class
- Nirmatrelvir und Ritonavir
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for nirmatrelvir und ritonavir.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nirmatrelvir und ritonavir · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Nirmatrelvir und ritonavir in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPAXLOVIDPfizer Europe MA EEIG, Bruxelles
- NorwayPaxlovidPfizer Europe MA EEIG
- SpainPAXLOVID 150 MG + 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPfizer Europe Ma Eeig
- FinlandPaxlovidPfizer Europe MA EEIG
- FrancePAXLOVID 150 mg + 100 mg, comprimé pelliculéPFIZER EUROPE MA EEIG (BELGIQUE)
- IcelandPaxlovidPfizer Europe MA EEIG*
- NetherlandsPaxlovid 150 mg filmomhulde tabletten (PF-12345678) en 100 mg filmomhulde tabletten (ritonavir)Pfizer Europe MA EEIG
- PolandPaxlovidPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Paxlovid
- Liechtenstein · Paxlovid
- Norway · Paxlovid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af022104-a1ed-4d07-9651-849605d34cb0 GET /v1/drugs/af022104-a1ed-4d07-9651-849605d34cb0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02524031",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J05AE30",
"schedule": [
"Prescription"
],
"drug_code": "101307",
"strengths": [
"150 MG",
"100 MG"
],
"ahfs_class": null,
"substances": [
"NIRMATRELVIR",
"RITONAVIR"
],
"product_categorization": null
}See everything about nirmatrelvir und ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.